ITEM VIEW

Pneumocystis pneumonia in South African children diagnosed by molecular methods

dc.contributor.authorMorrow, Brenda M.
dc.contributor.authorSamuel, Catherine M.
dc.contributor.authorZampoli, Marco
dc.contributor.authorWhitelaw, Andrew
dc.contributor.authorZar, Heather J.
dc.date.accessioned2014-05-30T09:44:06Z
dc.date.available2014-05-30T09:44:06Z
dc.date.issued2014-01
dc.identifier.citationMorrow, B. M. 2014. Pneumocystis pneumonia in South African children diagnosed by molecular methods. BMC Research Notes, 7(1):26, doi:10.1186/1756-0500-7-26.en_ZA
dc.identifier.issn1756-0500 (online)
dc.identifier.otherdoi:10.1186/1756-0500-7-26
dc.identifier.urihttp://hdl.handle.net/10019.1/86860
dc.descriptionPlease cite as follows:en_ZA
dc.descriptionMorrow, B. M. 2014. Pneumocystis pneumonia in South African children diagnosed by molecular methods. BMC Research Notes, 7(1):26, doi:10.1186/1756-0500-7-26.en_ZA
dc.descriptionThe original publication is available at http://www.biomedcentral.com/1756-0500/7/26en_ZA
dc.description.abstractAbstract Background Pneumocystis pneumonia (PCP) is an important cause of hospitalization and mortality in HIV-infected children. However, the incidence of PCP has been underestimated due to poor sensitivity of diagnostic tests. The use of polymerase chain reaction (PCR) for pneumocystis has enabled more reliable diagnosis. This study describes the incidence, clinical features and outcome of PCP in South African children diagnosed using PCR. Methods A prospective study of children hospitalised in South Africa with suspected PCP was done from November 2006 to August 2008. Clinical, laboratory and radiological information were collected. Lower respiratory tract specimens were obtained for PCP immunofluorescence (IF), real- time PCR for pneumocystis, bacterial and mycobacterial culture. Nasopharyngeal aspirates were taken for immunofluorescence (IF), real-time PCR for pneumocystis and PCR for respiratory viruses. A blood specimen for bacterial culture and for cytomegalovirus PCR was taken. Children were followed for the duration of their hospitalisation and the outcome was recorded. Results 202 children [median (interquartile range, IQR) age 3.2 (2.1– 4.6) months] were enrolled; 124 (61.4%) were HIV infected. PCP was identified in 109 (54%) children using PCR, compared to 43 (21%) using IF and Grocott staining (p < 0.0001). Most PCP cases (88, 81%) occurred in HIV-infected children. All 21 cases (19%) occurring in HIV- negative children had another risk factor for PCP. On logistic regression, predictive factors for PCP were HIV infection, lack of fever, high respiratory rate and low oxygen saturation whilst cotrimoxazole prophylaxis was protective (OR 0.24; 95% CI 0.1 to 0.5; p < 0.002). The case fatality of children with PCP was higher than those without PCP (32.1% versus 17.2%; relative risk 1.87; 95% confidence interval (CI) 1.11 – 3.15). Amongst HIV-infected children, a CD4 less than 15% was the only independent predictor of mortality. Conclusions The diagnostic yield for PCP is more than 2.5 times higher on PCR than other detection methods. PCP is a very common cause of severe hypoxic pneumonia and is associated with high mortality in HIV-infected African infants.en_ZA
dc.description.sponsorshipNHLS Research Trust granten_ZA
dc.description.sponsorshipNational Research Foundation of South Africaen_ZA
dc.description.sponsorshipMedical Research Council of South Africaen_ZA
dc.description.sponsorshipASTRA-Zeneca Respiratory Award from the South African Thoracic Societyen_ZA
dc.format.extent6 p.
dc.language.isoen_ZAen_ZA
dc.publisherBioMed Centralen_ZA
dc.subjectPneumocystic pneumonia in children -- Diagnostic testsen_ZA
dc.subjectChildren with HIV -- Diseases -- Diagnostic testsen_ZA
dc.subjectAIDS (Disease) in children -- Lung diseases -- Diagnostic testsen_ZA
dc.subjectPneumocystic pneumonia (PCP) -- Diagnosis -- South Africaen_ZA
dc.subjectPneumocystic pneumonia in children -- Treatmenten_ZA
dc.subjectInfant -- Mortality -- South Africaen_ZA
dc.titlePneumocystis pneumonia in South African children diagnosed by molecular methodsen_ZA
dc.typeArticleen_ZA
dc.date.updated2014-01-13T16:24:18Z
dc.description.versionPublishers' Versionen_ZA
dc.rights.holderBrenda M Morrow et al.; licensee BioMed Central Ltd.en_ZA


Files in this item

Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

ITEM VIEW